ClinicalTrials.gg
Sign In

Soft Tissue Infections clinical trials

The registry lists 92 studies for Soft Tissue Infections across more than 10 countries. 14 are recruiting or about to start. 44 of them are mainly about Soft Tissue Infections (how this is decided). Per ClinicalTrials.gov, last updated 2026-10-23.

Get an email when these change. Save the Soft Tissue Infections studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed
60
Terminated
8
Recruiting
8
Withdrawn
5
Status unknown
4
Not yet recruiting
4

Phase

Phase 3
13
Phase 4
11
Phase 2
7
Phase 1
5
Early Phase 1
1

Where

United States
39
Italy
10
Greece
7
Spain
7
Argentina
7
Bulgaria
6

Who runs them

Pfizer (6) · Paratek Pharmaceuticals Inc (3) · Merck Sharp & Dohme LLC (3) · GBR Academy (3) · Inflammatix (3) · Ole Hyldegaard (3) · London Health Sciences Centre Research Institute and Lawson Research Institute of St. Joseph's (2) · Motif Bio (2)

What is being tested here

Drugs under test in Soft Tissue Infections studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

DrugOpenPhase 3All
Naproxen111
Daptomycin026
Omadacycline033
Chlorhexidine gluconate002
Chlorhexidine002
Iclaprim022
Ceftaroline022
Mupirocin001
Povidone-Iodine001
Tedizolid phosphate011

Coming up

1phase 3 study under way
7studies finish main data collection within a year

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

All 7

Who these studies take

Of the 8 Soft Tissue Infections studies recruiting now, 5 (63%) set no upper age limit and 3 (38%) stop at 75 or younger. 2 (25%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 2 (25%) take healthy volunteers.

Recruiting studies that take each age, of 8
AgeWomenMen
102 (25%)2 (25%)
188 (100%)8 (100%)
307 (88%)7 (88%)
407 (88%)7 (88%)
507 (88%)7 (88%)
656 (75%)6 (75%)
755 (63%)5 (63%)
855 (63%)5 (63%)

Across all 92 studies, recruiting or not: 21% stop at 75 or younger and 18% at 65; 21% take children; 1% are for women only and 1% for men only; 14% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

How long Soft Tissue Infections studies take

Of 14 interventional studies with no phase under Soft Tissue Infections, half reached primary completion within 32 months of starting, counting those still running.

Start to primary completionEvery sponsorIndustryNon-industry
Interventional, no phase32 mo25–45 · 14 studies——

Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out

Studies

Recruiting first, then most recently updated. Showing 50 of 92. Browse all 92 → or search them.